Two deaths -- one each in Kerala and Maharashtra -- have been...
Category:
Health
Latest
Sitting at work for long? 15-30 mins of extra exercise can cut high death risk
The study, published in the journal JAMA Network Open, suggests...
60% kids under-5 in India are micronutrient deficient, 40% anaemic: AIIMS
“The high prevalence of anaemia indicates that anaemia is a serious...
COVID-19 vaccine: European medicines watchdog approves Moderna jab for ages 12 and up
The vaccine will be given in two injections, each four weeks apart. The decision by the Amsterdam-based agency follows the approval of the first vaccine for European youngsters, by Pfizer/BioNTech in May. The effects of Spikevax have been studied among 3,732 children aged 12 to 17 years, the EMA said.
Doc-population ratio 1:854, assuming 80% availability of allopathic docs, 5.65 lakh AYUSH docs: Govt
New Delhi: There is one doctor for every 854 people in the country, assuming 80 per cent availability of registered allopathic doctors and 5.65 lakh AYUSH doctors, Lok Sabha was informed on Friday. In a written reply, Minister of State for Health Bharati Pravin...
3rd Covid wave may occur either due to mutations in virus or pool of susceptible population: Govt
”The (third) wave may occur either due to mutations in the virus or due to the available pool of susceptible population, which in turn is also dependent on various pharmaceutical and non-pharmaceutical interventions for management of the pandemic,” Union Health Minister Mansukh Mandaviya said.
India urges foreign governments to easing travel restrictions for Indians
To a question on when the World Health Organisation (WHO) is expected to recognise Covaxin vaccine, he said its producer Bharat Biotech Limited has submitted the request along with all necessary documentation to the global body earlier this month.
Bagchi also said that more than half of the member states of the European Union have recognised Covishield, the vaccine manufactured by Pune-based Serum Institute of India.
The virus will not mutate “dramatically” in the forthcoming months.: Dr Randeep Guleria on Covid 19
“Third wave’s arrival is a lot dependent on how we behave. COVID appropriate behaviour like preventing crowds, and other measures can delay the third wave and severity of the third wave. Thus, it is dependent is human behaviour. We cannot predict that how the virus will behave.”
Chemicals found in consumer products could increase breast cancer risk: Study
For instance, in 2002, when the Women’s Health Initiative study found combination hormone replacement therapy to be associated with an increased risk of breast cancer, women stopped taking the drugs and incidence rates went down.
Work from home future fades in Asia as companies seek more office space
The study also found that almost half of the Asian companies prefer dedicated seats for their staff, rather than sharing in what’s known as “hot-desking,” since most of them don’t intend to adopt hybrid work. While more than 60 per cent of the respondents said the staff-to-desk sharing ratio will increase over the coming couple of years, most of them were Western companies. That means an office desk will serve more employees in the future.
J&J forecasts $2.5 bln in 2021 COVID-19 vaccine sales, sets lower production target
J&J estimated its vaccine price at $5 per dose in the first half of the year and said it would likely be as much as $8 by year end. The healthcare conglomerate, which promised it would not make a profit on the vaccine during the pandemic, said the fluctuating price reflected the net costs of the vaccine and production volumes. The $8 price is a bit lower than previous indications. South Africa has said it is paying $10 per dose for both the J&J and the two-shot Pfizer/BioNTech vaccines. AstraZeneca Plc is charging $3 per shot for its two-dose vaccine.
645 children lost their parents to Covid from Apr-May 28 during second wave: WCD
”The scheme, the prime minister has announced, provides support for education and health and will create a corpus of Rs 10 lakh for each child when he or she reaches 18 years of age. This corpus will be used to give a monthly financial support/ stipend form 18 years of age, for the next five years to take care of his or her personal requirements during the period of higher education and on reaching the age of 23 years, he or she will get the corpus amount as one lump-sum for personal and professional use,” Irani said.
Based on audacious assumptions: Centre dismisses studies claiming undercounting of India’s COVID deaths
“The reports assume that all the excess mortality figures are COVID deaths, which is not based on facts and totally fallacious. Excess mortality is a term used to describe an all-cause mortality figure and attributing these deaths to COVID-19 is completely misleading,” it said.